Saltar al contenido
Merck

Preventive effects of rapamycin on inflammation and capillary degeneration in a rat model of NMDA-induced retinal injury.

Biological & pharmaceutical bulletin (2015-03-10)
Yuto Aoki, Tsutomu Nakahara, Daiki Asano, Hiroko Ushikubo, Asami Mori, Kenji Sakamoto, Kunio Ishii
RESUMEN

Inhibitors of the mammalian target of rapamycin (mTOR) have been shown to protect against neuronal injury, but the mechanisms underlying this effect are not fully understood. The present study aimed to examine the effects of rapamycin, an inhibitor of the mTOR pathway, on inflammation and capillary degeneration in a rat model of N-methyl-D-aspartate (NMDA)-induced retinal neurotoxicity. Inflammation and capillary degeneration were evaluated by counting the numbers of CD45-positive leukocytes and Iba1-positive microglia, and by measuring the length of empty basement membrane sleeves, respectively. Marked increases in the numbers of leukocytes and microglia were observed 1 d after intravitreal injection of NMDA (200 nmol), and significant capillary degeneration was observed after 7 d. These NMDA-induced changes were significantly reduced by the simultaneous injection of rapamycin (20 nmol) with NMDA. These results suggest that rapamycin has preventive effects on inflammation and capillary degeneration during retinal injury.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Dimetilsulfóxido, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimetilsulfóxido, Molecular Biology
Sigma-Aldrich
Dimetilsulfóxido, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimetilsulfóxido, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimetilsulfóxido, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Dimetilsulfóxido, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Dimetilsulfóxido, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Dimetilsulfóxido, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Rapamycin, Ready Made Solution, 2.5 mg/mL in DMSO (2.74 mM), from Streptomyces hygroscopicus
Sigma-Aldrich
N-Methyl-D-aspartic acid, ≥98% (TLC), solid
Sigma-Aldrich
Dimetilsulfóxido, PCR Reagent
Supelco
Rapamycin, VETRANAL®, analytical standard
Supelco
Dimetilsulfóxido, analytical standard
Supelco
Dimetilsulfóxido, for inorganic trace analysis, ≥99.99995% (metals basis)
USP
Dimetilsulfóxido, United States Pharmacopeia (USP) Reference Standard
Pentobarbital, European Pharmacopoeia (EP) Reference Standard
Dimetilsulfóxido, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
Dimetilsulfóxido, ≥99.6%, ReagentPlus®